(Q54379716)
Statements
Clinical activity and tolerability of enzalutamide (MDV3100) in patients with metastatic, castration-resistant prostate cancer who progress after docetaxel and abiraterone treatment. (English)
Sushil Badrising
Vincent van der Noort
H Pieter van den Berg
Maartje Los
Paul Hamberg
Jules L Coenen
Alfons J M van den Eertwegh
Igle J de Jong
Emile D Kerver
Harm van Tinteren
30 December 2013